Tezspire 110 mg/ml

Tezspire 110 mg/ml is a medicine authorised by Swissmedic under authorisation number 69080. The authorisation holder is AstraZeneca AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 August 2023 and the authorisation is limited until 22 August 2028. ATC code R03DX11 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 69080
  • ATC R03DX11
  • Biotechnological medicines
Authorisation data
Authorisation number69080
NameTezspire 110 mg/ml
Full nameTezspire 110 mg/ml, Injektionslösung in einem Fertigpen
Authorisation holderAstraZeneca AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeR03DX11
First authorisation23 August 2023
Authorisation validity22 August 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Tezspire 110 mg/ml, Injektionslösung in einem FertigpenB23 August 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Injektor(en), vorgefüllt/PenR03DX1103.04.5.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Tezspire 110 mg/ml authorised in Switzerland?

Yes. Tezspire 110 mg/ml is authorised by Swissmedic under authorisation number 69080, data as of 01 September 2026. The authorisation is limited until 22 August 2028.

Which dispensing category does Tezspire 110 mg/ml have?

Tezspire 110 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Tezspire 110 mg/ml?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com